{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:18:38Z","timestamp":1791818318164,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"50","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81991511"],"award-info":[{"award-number":["81991511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81991510"],"award-info":[{"award-number":["81991510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100155"],"award-info":[{"award-number":["82100155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M720060"],"award-info":[{"award-number":["2022M720060"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,12,8]]},"DOI":"10.1038\/s41388-023-02874-5","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:01:58Z","timestamp":1698066118000},"page":"3657-3669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Low doses of IFN-\u03b3 maintain self-renewal of leukemia stem cells in acute myeloid leukemia"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1970-4537","authenticated-orcid":false,"given":"Xiaoling","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-0425","authenticated-orcid":false,"given":"Honghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-6680","authenticated-orcid":false,"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-4781","authenticated-orcid":false,"given":"Xiaochun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"2874_CR1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176:1265\u201381 e24.","journal-title":"Cell"},{"key":"2874_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"2874_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ccell.2020.10.010","volume":"38","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Pioso MS, Olesinski EA, Yilma B, Ryan JA, Mashaka T, et al. Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia. Cancer Cell. 2020;38:872\u201390 e6.","journal-title":"Cancer Cell"},{"key":"2874_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.stem.2018.10.016","volume":"24","author":"SM Park","year":"2019","unstructured":"Park SM, Cho H, Thornton AM, Barlowe TS, Chou T, Chhangawala S, et al. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation. Cell Stem Cell. 2019;24:153\u201365 e7.","journal-title":"Cell Stem Cell"},{"key":"2874_CR5","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1172\/JCI120654","volume":"129","author":"S Piya","year":"2019","unstructured":"Piya S, Mu H, Bhattacharya S, Lorenzi PL, Davis RE, McQueen T, et al. BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment. J Clin Investig. 2019;129:1878\u201394.","journal-title":"J Clin Investig"},{"key":"2874_CR6","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","volume":"129","author":"N Hein","year":"2017","unstructured":"Hein N, Cameron DP, Hannan KM, Nguyen NN, Fong CY, Sornkom J, et al. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood. 2017;129:2882\u201395.","journal-title":"Blood"},{"key":"2874_CR7","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.smim.2019.05.002","volume":"43","author":"JD Burke","year":"2019","unstructured":"Burke JD, Young HA. IFN-gamma: A cytokine at the right time, is in the right place. Semin Immunol. 2019;43:101280.","journal-title":"Semin Immunol"},{"key":"2874_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","volume":"9","author":"F Castro","year":"2018","unstructured":"Castro F, Cardoso AP, Goncalves RM, Serre K, Oliveira MJ. Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. Front Immunol. 2018;9:847.","journal-title":"Front Immunol"},{"key":"2874_CR9","doi-asserted-by":"publisher","first-page":"25656","DOI":"10.1074\/jbc.M116.753145","volume":"291","author":"K Fatehchand","year":"2016","unstructured":"Fatehchand K, McMichael EL, Reader BF, Fang H, Santhanam R, Gautam S, et al. Interferon-gamma Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem. 2016;291:25656\u201366.","journal-title":"J Biol Chem"},{"key":"2874_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18:545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"2874_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ijc.2910430211","volume":"43","author":"HH Bartsch","year":"1989","unstructured":"Bartsch HH, Pfizenmaier K, Hanusch A, Scheurich P, Ucer U, Nagel GA. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation. Int J Cancer. 1989;43:235\u201340.","journal-title":"Int J Cancer"},{"key":"2874_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/jir.1996.16.217","volume":"16","author":"J Thiele","year":"1996","unstructured":"Thiele J, Zirbes TK, Kvasnicka HM, Lorenzen J, Niederle N, Leder LD, et al. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res. 1996;16:217\u201324.","journal-title":"J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res"},{"key":"2874_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00000421-199304000-00017","volume":"16","author":"RM Stone","year":"1993","unstructured":"Stone RM, Spriggs DR, Arthur KA, Mayer RJ, Griffin J, Kufe DW. Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes. Am J Clin Oncol. 1993;16:159\u201363.","journal-title":"Am J Clin Oncol"},{"key":"2874_CR14","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.4049\/jimmunol.165.10.5502","volume":"165","author":"GL Beatty","year":"2000","unstructured":"Beatty GL, Paterson Y. IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen. J Immunol. 2000;165:5502\u20138.","journal-title":"J Immunol"},{"key":"2874_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-gamma in tumor progression and regression: a review. Biomarker Res. 2020;8:49.","journal-title":"Biomarker Res"},{"key":"2874_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1089\/jir.2018.0087","volume":"39","author":"MR Zaidi","year":"2019","unstructured":"Zaidi MR. The Interferon-Gamma Paradox in Cancer. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res. 2019;39:30\u20138.","journal-title":"J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res"},{"key":"2874_CR17","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","volume":"17","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Merlino G. The two faces of interferon-gamma in cancer. Clinical Cancer Res: Official J Am Assoc Cancer Res. 2011;17:6118\u201324.","journal-title":"Clinical Cancer Res: Official J Am Assoc Cancer Res"},{"key":"2874_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature09666","volume":"469","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, et al. Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature. 2011;469:548\u201353.","journal-title":"Nature"},{"key":"2874_CR19","doi-asserted-by":"publisher","first-page":"eabh2548","DOI":"10.1126\/scitranslmed.abh2548","volume":"14","author":"B Zhu","year":"2022","unstructured":"Zhu B, Zhong W, Cao X, Pan G, Xu M, Zheng J, et al. Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice. Sci Transl Med. 2022;14:eabh2548.","journal-title":"Sci Transl Med"},{"key":"2874_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41556-020-0495-y","volume":"22","author":"S Singh","year":"2020","unstructured":"Singh S, Kumar S, Srivastava RK, Nandi A, Thacker G, Murali H, et al. Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-gamma signalling. Nat Cell Biol. 2020;22:591\u2013602.","journal-title":"Nat Cell Biol"},{"key":"2874_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442:818\u201322.","journal-title":"Nature"},{"key":"2874_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14590-9","volume":"11","author":"Y Sheng","year":"2020","unstructured":"Sheng Y, Yu C, Liu Y, Hu C, Ma R, Lu X, et al. FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML. Nat Commun. 2020;11:928.","journal-title":"Nat Commun"},{"key":"2874_CR23","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, et al. The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327:1650\u20133.","journal-title":"Science"},{"key":"2874_CR24","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/onc.2016.416","volume":"36","author":"S Goyama","year":"2017","unstructured":"Goyama S, Shrestha M, Schibler J, Rosenfeldt L, Miller W, O\u2019Brien E, et al. Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia. Oncogene. 2017;36:2589\u201398.","journal-title":"Oncogene"},{"key":"2874_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","volume":"10","author":"TC Somervaille","year":"2006","unstructured":"Somervaille TC, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell. 2006;10:257\u201368.","journal-title":"Cancer Cell"},{"key":"2874_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","volume":"21","author":"WJ Harris","year":"2012","unstructured":"Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y, et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell. 2012;21:473\u201387.","journal-title":"Cancer Cell"},{"key":"2874_CR27","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1038\/s41375-022-01697-9","volume":"36","author":"H Boutzen","year":"2022","unstructured":"Boutzen H, Madani Tonekaboni SA, Chan-Seng-Yue M, Murison A, Takayama N, Mbong N, et al. A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome. Leukemia. 2022;36:2690\u2013704.","journal-title":"Leukemia"},{"key":"2874_CR28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Cancer Discov. 2017;7:716\u201335.","journal-title":"Cancer Discov"},{"key":"2874_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ijc.31357","volume":"143","author":"Y Gao","year":"2018","unstructured":"Gao Y, Yang J, Cai Y, Fu S, Zhang N, Fu X, et al. IFN-gamma-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling. Int J Cancer. 2018;143:931\u201343.","journal-title":"Int J Cancer"},{"key":"2874_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1182\/bloodadvances.2018020503","volume":"3","author":"A Yokota","year":"2019","unstructured":"Yokota A, Hirai H, Sato R, Adachi H, Sato F, Hayashi Y, et al. C\/EBPbeta is a critical mediator of IFN-alpha-induced exhaustion of chronic myeloid leukemia stem cells. Blood Adv. 2019;3:476\u201388.","journal-title":"Blood Adv"},{"key":"2874_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2006.05.025","volume":"10","author":"B Kovacic","year":"2006","unstructured":"Kovacic B, Stoiber D, Moriggl R, Weisz E, Ott RG, Kreibich R, et al. STAT1 acts as a tumor promoter for leukemia development. Cancer Cell. 2006;10:77\u201387.","journal-title":"Cancer Cell"},{"key":"2874_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/leu.2016.209","volume":"31","author":"L Quotti Tubi","year":"2017","unstructured":"Quotti Tubi L, Canovas Nunes S, Brancalion A, Doriguzzi Breatta E, Manni S, Mandato E, et al. Protein kinase CK2 regulates AKT, NF-kappaB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia. Leukemia. 2017;31:292\u2013300.","journal-title":"Leukemia"},{"key":"2874_CR33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nm.4477","volume":"24","author":"B Guo","year":"2018","unstructured":"Guo B, Huang X, Lee MR, Lee SA, Broxmeyer HE. Antagonism of PPAR-gamma signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis. Nat Med. 2018;24:360\u20137.","journal-title":"Nat Med"},{"key":"2874_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature15248","volume":"525","author":"S Prost","year":"2015","unstructured":"Prost S, Relouzat F, Spentchian M, Ouzegdouh Y, Saliba J, Massonnet G, et al. Erosion of the chronic myeloid leukaemia stem cell pool by PPARgamma agonists. Nature. 2015;525:380\u20133.","journal-title":"Nature"},{"key":"2874_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1046\/j.0022-202X.2004.22237.x","volume":"122","author":"M Kortylewski","year":"2004","unstructured":"Kortylewski M, Komyod W, Kauffmann ME, Bosserhoff A, Heinrich PC, Behrmann I. Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals. J Invest Dermatol. 2004;122:414\u201322.","journal-title":"J Invest Dermatol"},{"key":"2874_CR36","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.18632\/oncotarget.6693","volume":"7","author":"F Bahram","year":"2016","unstructured":"Bahram F, Hydbring P, Tronnersjo S, Zakaria SM, Frings O, Fahlen S, et al. Interferon-gamma-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation. Oncotarget. 2016;7:2837\u201354.","journal-title":"Oncotarget"},{"key":"2874_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/sj.bjc.6690491","volume":"80","author":"F Burke","year":"1999","unstructured":"Burke F, Smith PD, Crompton MR, Upton C, Balkwill FR. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA. Br J Cancer. 1999;80:1236\u201344.","journal-title":"Br J Cancer"},{"key":"2874_CR38","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1038\/sj.onc.1202217","volume":"17","author":"S Kominsky","year":"1998","unstructured":"Kominsky S, Johnson HM, Bryan G, Tanabe T, Hobeika AC, Subramaniam PS, et al. IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1\/CIP1. Oncogene. 1998;17:2973\u20139.","journal-title":"Oncogene"},{"key":"2874_CR39","doi-asserted-by":"publisher","first-page":"19712","DOI":"10.1074\/jbc.M313023200","volume":"279","author":"C Ruiz-Ruiz","year":"2004","unstructured":"Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A. The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem. 2004;279:19712\u201320.","journal-title":"J Biol Chem"},{"key":"2874_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gut.49.2.251","volume":"49","author":"KM Detjen","year":"2001","unstructured":"Detjen KM, Farwig K, Welzel M, Wiedenmann B, Rosewicz S. Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut. 2001;49:251\u201362.","journal-title":"Gut"},{"key":"2874_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/jir.2012.0087","volume":"33","author":"S Balachandran","year":"2013","unstructured":"Balachandran S, Adams GP. Interferon-gamma-induced necrosis: an antitumor biotherapeutic perspective. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res. 2013;33:171\u201380.","journal-title":"J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res"},{"key":"2874_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","volume":"1182","author":"CH Miller","year":"2009","unstructured":"Miller CH, Maher SG, Young HA. Clinical Use of Interferon-gamma. Ann N Y Acad Sci. 2009;1182:69\u201379.","journal-title":"Ann N Y Acad Sci"},{"key":"2874_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.07.005","volume":"31","author":"MA Kursunel","year":"2016","unstructured":"Kursunel MA, Esendagli G. The untold story of IFN-gamma in cancer biology. Cytokine Growth Factor Rev. 2016;31:73\u201381.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2874_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13666-5","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen X, Burkhardt DB, Hartman AA, Hu X, Eastman AE, Sun C, et al. MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors. Nat Commun. 2019;10:5767.","journal-title":"Nat Commun"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02874-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T10:03:48Z","timestamp":1702029828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02874-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":44,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023,12,8]]}},"alternative-id":["2874"],"URL":"https:\/\/doi.org\/10.1038\/s41388-023-02874-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}